Bimatoprost 0.0001 MG/MG Ophthalmic Gel — RxCUI 2725168
RxNorm drug concept · Semantic clinical drug
RxCUI 2725168
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2725168
Official nameBimatoprost 0.0001 MG/MG Ophthalmic Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbimatoprost 0.01 % Ophthalmic Gel
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bimatoprost Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Bimatoprost ophthalmic 0.03% is used to grow longer, thicker and darker eyelashes if you have hypotrichosis, meaning sparse lashes. Lumigan is a related bimatoprost eye drop used f...
- Do it once at night on a clean face with makeup and contacts out. Put one drop on the sterile applicator and brush it along the upper lid at the base of the lashes. Blot extra, and...
- No. Extra applications will not increase growth. If you stop, your lashes are expected to return to how they were before treatment.
- Will using more make my lashes grow more?
🕸️ Concept Web — How Bimatoprost 0.0001 MG/MG Ophthalmic Gel Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bimatoprost 0.0001 MG/MG Ophthalmic Gel
RxCUI 2725168 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Bimatoprost
283810IN
-
Bimatoprost
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zolymbus
2725616BN
-
Zolymbus
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bimatoprost Ophthalmic Gel
2725167SCDF -
Bimatoprost Ophthalmic Product
1161198SCDG -
Bimatoprost Ophthalmic Gel [Zolymbus]
2725619SBDF -
Zolymbus Ophthalmic Product
2725618SBDG -
Ophthalmic Gel
316963DF -
Ophthalmic Product
1151135DFG
-
Bimatoprost Ophthalmic Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bimatoprost 0.0001 MG/MG
2725166SCDC -
Bimatoprost 0.0001 MG/MG Ophthalmic Gel [Zolymbus]
2725620SBD -
Bimatoprost 0.0001 MG/MG [Zolymbus]
2725617SBDC
-
Bimatoprost 0.0001 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bimatoprost 0.0001 MG/MG
SCDC · 2725166 -
Bimatoprost Ophthalmic Gel
SCDF · 2725167 -
Bimatoprost Ophthalmic Product
SCDG · 1161198
Brand-Name Concepts
-
Bimatoprost 0.0001 MG/MG Ophthalmic Gel [Zolymbus]
SBD · 2725620 -
Bimatoprost 0.0001 MG/MG [Zolymbus]
SBDC · 2725617 -
Bimatoprost Ophthalmic Gel [Zolymbus]
SBDF · 2725619 -
Zolymbus Ophthalmic Product
SBDG · 2725618 -
Zolymbus
BN · 2725616
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 2725168 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82584-0010-10 | 1 POUCH in 1 CARTON (82584-010-10) / 10 VIAL, SINGLE-DOSE i... | ZOLYMBUS | Thea Pharma Inc. | 2026-02-26 |
| 82584-0010-30 | 3 POUCH in 1 CARTON (82584-010-30) / 10 VIAL, SINGLE-DOSE i... | ZOLYMBUS | Thea Pharma Inc. | 2026-02-26 |
| 82584-0010-35 | 3 POUCH in 1 CARTON (82584-010-35) / 10 VIAL, SINGLE-DOSE i... | ZOLYMBUS | Thea Pharma Inc. | 2026-02-26 |
Observed labelers:
Thea Pharma Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.